» Articles » PMID: 36582273

Extracardiovascular Injury Complications in Kawasaki Disease

Overview
Specialty Pediatrics
Date 2022 Dec 30
PMID 36582273
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: Patients with Kawasaki disease (KD) experience various extracardiovascular injury complications, which may affect their outcomes.

Objective: To investigate the incidence and clinical characteristics of extracardiovascular complications in children with KD.

Methods: The clinical data of patients diagnosed with KD in the First Affiliated Hospital of Guangxi Medical University from January 2003 to January 2021 were reviewed. The clinical characteristics and extracardiovascular complications were compared among patients stratified by age, intravenous immunoglobulin (IVIG) therapy responsiveness, and coronary status.

Results: A total of 511 patients with KD were included, 357 (69.9%) were aged 1-5 years. Children aged <1 year (21.5%) and boys (70.8%) were more likely to have coronary artery lesions (CALs). The incidence of incomplete KD was lowest in 1-5-year-old patients (19.6%). Involvement of the hematological system gradually decreased with age (<1 year, 51.8%; 1-5 years, 36.7%; >5 years, 29.5%), whereas the involvement of the joints gradually increased with age (<1 year, 2.7%; 1-5 years, 6.2%; >5 years, 20.5%). Nervous system involvement was more common in IVIG non-responders (15.7% [13/83] . 5.4% [23/428], = 0.001). However, there were no significant differences in extracardiovascular injury complications between patients with or without CALs.

Interpretation: KD can involve multiple organ injuries as well as cardiovascular complications, and nervous systerm involvement may be more common in patients unresponsive to IVIG.

Citing Articles

Diagnostic value of syndecan-1 for coronary artery lesions and correlation analysis of laboratory indicators in Kawasaki disease patients.

Dai L, Zhang L, He J, Huang R, Tang W, Guo H Ital J Pediatr. 2024; 50(1):209.

PMID: 39385218 PMC: 11463127. DOI: 10.1186/s13052-024-01772-0.


Extracardiovascular injury complications in Kawasaki disease.

Liu J, Huang Y, Qin S, Su D, Ye B, Pang Y Pediatr Investig. 2022; 6(4):241-249.

PMID: 36582273 PMC: 9789935. DOI: 10.1002/ped4.12355.

References
1.
Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T . Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006; 113(22):2606-12. DOI: 10.1161/CIRCULATIONAHA.105.592865. View

2.
Yang S, Song R, Zhang J, Li X, Li C . Predictive tool for intravenous immunoglobulin resistance of Kawasaki disease in Beijing. Arch Dis Child. 2018; 104(3):262-267. DOI: 10.1136/archdischild-2017-314512. View

3.
Kitano N, Takeuchi T, Suenaga T, Kakimoto N, Naka A, Shibuta S . Seasonal Variation in Epidemiology of Kawasaki Disease-Related Coronary Artery Abnormalities in Japan, 1999-2017. J Epidemiol. 2020; 31(2):132-138. PMC: 7813765. DOI: 10.2188/jea.JE20190189. View

4.
Colomba C, La Placa S, Saporito L, Corsello G, Ciccia F, Medaglia A . Intestinal Involvement in Kawasaki Disease. J Pediatr. 2018; 202:186-193. DOI: 10.1016/j.jpeds.2018.06.034. View

5.
Xie L, Yan W, Huang M, Huang M, Chen S, Huang G . Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017. J Epidemiol. 2019; 30(10):429-435. PMC: 7492704. DOI: 10.2188/jea.JE20190065. View